pyrrolidonecarboxylic acid and Substance Withdrawal Syndrome

pyrrolidonecarboxylic acid has been researched along with Substance Withdrawal Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pekary, AE; Sattin, A; Senanayake, SS1
Baláspiri, L; Kovács, GL; Szontágh, L; Telegdy, G1
Breda, A; Dotta, C; Gelso, E; Moretto, F; Pace, M; Rizzo, A; Sanzuol, F; Tossani, C1
Iakovlev, VA1
Fekete, C; Lechan, RM; Legradi, G; Mihaly, E1
Belloni, G; Bono, G; Gelso, E; Merlo, P; Sinforiani, E; Soldati, M1
Bansinath, M; Bhargava, HN; Das, S; Prasad, R1

Trials

3 trial(s) available for pyrrolidonecarboxylic acid and Substance Withdrawal Syndrome

ArticleYear
[Therapeutic use of metadoxine in chronic alcoholism. Double blind study of patients in a department of general medicine].
    La Clinica terapeutica, 1993, Volume: 142, Issue:3

    Topics: Alcoholic Intoxication; Alcoholism; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Hospital Departments; Humans; Italy; Male; Middle Aged; Pyridoxine; Pyrrolidonecarboxylic Acid; Substance Withdrawal Syndrome

1993
[The treatment of alcoholism with metadoxil].
    Voenno-meditsinskii zhurnal, 1999, Volume: 320, Issue:10

    Topics: Adult; Alcohol Deterrents; Alcoholism; Drug Combinations; Drug Therapy, Combination; Ethanol; Humans; Male; Middle Aged; Pyridoxine; Pyrrolidonecarboxylic Acid; Substance Withdrawal Syndrome; Time Factors

1999
Alcoholic abstinence syndrome: short-term treatment with metadoxine.
    International journal of clinical pharmacology research, 1991, Volume: 11, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Drug Combinations; Ethanol; Humans; Male; Middle Aged; Pyridoxine; Pyrrolidonecarboxylic Acid; Substance Withdrawal Syndrome

1991

Other Studies

4 other study(ies) available for pyrrolidonecarboxylic acid and Substance Withdrawal Syndrome

ArticleYear
Lithium modulates expression of TRH receptors and TRH-related peptides in rat brain.
    Neuroscience, 2002, Volume: 115, Issue:1

    Topics: Acute Disease; Animals; Brain; Chromatography, High Pressure Liquid; Drug Administration Schedule; Lithium Chloride; Male; Neuropeptides; Protein Binding; Protein Precursors; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Thyrotropin-Releasing Hormone; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone

2002
Dipeptides delay the onset of morphine withdrawal in the mouse.
    Acta physiologica Hungarica, 1984, Volume: 63, Issue:1

    Topics: Analysis of Variance; Animals; Dipeptides; Humans; Male; Mice; Morphine; Morphine Dependence; Naloxone; Pyrrolidonecarboxylic Acid; Substance Withdrawal Syndrome

1984
Efferent projections of ProTRH neurons in the ventrolateral periaqueductal gray.
    Brain research, 2001, Nov-23, Volume: 919, Issue:2

    Topics: Animals; Autonomic Nervous System; Axonal Transport; Brain; Efferent Pathways; Fluorescent Antibody Technique; Male; Microinjections; Neurons; Opioid-Related Disorders; Periaqueductal Gray; Phytohemagglutinins; Presynaptic Terminals; Protein Precursors; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone

2001
The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:1

    Topics: Animals; Brain; Cell Membrane; Drug Tolerance; Male; Morphine; Morphine Dependence; Naloxone; Pituitary Gland; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1989